Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BlueSky Vaccines

BlueSky Vaccines?uq=oeHSfu7P
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
4 INVESTORS
Description

Owner and operator of a biotherapeutic company intended to exploit the potential of virotherapy against cancer. The company's biotherapeutic service performs clinical-stage development of virotherapy for treatment of malignant tumors by combining tumor cell killing activities of oncolytic viruses with immunostimmulatory transgenes and antigenes, enabling doctors to get oncolytic vaccines and treat cancers.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Am Heumarkt 7/39
  • Vienna, 1030
  • Austria

+43 0699 00000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BlueSky Vaccines’s full profile, request a free trial.

BlueSky Vaccines Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant Completed Startup
2. Accelerator/Incubator Completed Startup
1. Capitalization 01-Jan-2013 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BlueSky Vaccines Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Austria Wirtschaftsservice Other 000 0000 000000 0
INiTS Universit√§res Gr√ľnderservice Accelerator/Incubator Minority 000 0000 000000 0
The Austrian Research Promotion Agency Government 000 0000 000000 0
Wirtschaftsagentur Wien Government 000 0000 000000 0

BlueSky Vaccines Executive Team (4)

Name Title Board
Seat
Contact
Info
Thomas Muster Co-Founder, Supervisory Board Member & Chief Executive Officer
Michael Tscheppe Co-Founder, Chief Financial Officer & Managing Director
Markus Wolschek Ph.D Co-Founder, Scientific Director & Chief Scientific Officer
Josef Poandl Co-Founder